TAE Life Sciences to Develop Groundbreaking Therapy for Difficult-to-Treat Cancers, including Head, Neck and GBM; Announces $40 Million Series A Funding

Company Becomes First to License TAE Technologies' Accelerator-based Beam Technology for Clinical Investigation FOOTHILL RANCH, Calif., March 12, 2018 -- (Healthcare Sales & Marketing Network) -- TAE Life Sciences, a medical technology company develop... Devices, Oncology, Venture Capital, Personnel TAE Life Sciences, neutron beam, radiotherapy

http://salesandmarketingnetwork.com/news_release_bs.html?ID=2043612

Source: HSMN NewsFeed - March 12, 2018 Category: Pharmaceuticals Source Type: news